SAN FRANCISCO--(BUSINESS WIRE)--Unlearn®, the only artificial intelligence (AI) company developing prognostic digital twins to run smaller, faster clinical trials, today announced that the European ...
SAN FRANCISCO--(BUSINESS WIRE)--Unlearn®, a company at the forefront of AI in the clinical trial space, today announced the launch of TrialPioneer. This web-based application is free for teams in ...
Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with ...
SAN FRANCISCO, CA AND NEW YORK, NY / ACCESS Newswire / February 24, 2026 / Unlearn, a leading artificial intelligence company in the clinical development space, today announced its use of data from ...
AI-generated digital twins to strengthen SOLA's early-phase ALS study and support disciplined, data-driven development decisions SAN FRANCISCO, CA / ACCESS Newswire / March 10, 2026 / Unlearn, a ...
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results